A new technology for cellular immunotherapy showed promising anti-tumor activity in the lab against hard-to-treat cancers driven by the once-considered "undruggable" KRAS mutation, including lung, colorectal, and pancreatic.
from Latest Science News -- ScienceDaily https://ift.tt/3y8xm4t
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment